Liontrust Investment Partners’s Zimmer Biomet ZBH Stock Holding History

Liontrust Investment Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,784	Closed	-$984K	–	211
2025 Q2	$984K	Hold	10,784	–	–	0.01%	164
2025 Q1	$1.22M	Hold	10,784	–	–	0.02%	166
2024 Q4	$1.14M	Sell	10,784 -224	-2%	-$24K	0.02%	166
2024 Q3	$1.19M	Hold	11,008	–	–	0.02%	164
2024 Q2	$1.19M	Sell	11,008 -123,287	-92%	-$14.5M	0.02%	164
2024 Q1	$17.7M	Sell	134,295 -3,123	-2%	-$390K	0.25%	73
2023 Q4	$16.7M	Sell	137,418 -14,423	-9%	-$1.61M	0.24%	70
2023 Q3	$17M	Sell	151,841 -28,002	-16%	-$3.56M	0.27%	63
2023 Q2	$26.2M	Sell	179,843 -108,057	-38%	-$14.7M	0.38%	42
2023 Q1	$37.2M	Buy	+287,900	New	+$36.1M	0.54%	37
2022 Q4	–	Sell	-87,063	Closed	-$9.1M	–	248
2022 Q3	$9.1M	Sell	87,063 -192,237	-69%	-$21.1M	0.15%	78
2022 Q2	$29.3M	Buy	+279,300	New	+$33.1M	0.41%	45

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Liontrust Investment Partners's ZBH Position: Q3 2025 in Review

Liontrust Investment Partners sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 10,784 shares — an estimated $984K sold.

Liontrust Investment Partners first reported a position in ZBH in Q2 2022 and held it in 12 quarters. The position peaked at $37.2M in Q1 2023. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.

Liontrust Investment Partners reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
Liontrust Investment Partners sold 10,784 Zimmer Biomet shares in Q3 2025, an estimated $984K.
Liontrust Investment Partners first reported a position in Zimmer Biomet in Q2 2022 and held it in 12 quarters.
Liontrust Investment Partners's Zimmer Biomet position peaked at $37.2M in Q1 2023.
966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.

Based on Liontrust Investment Partners's 13F filing for Q3 2025, filed 24 Nov 2025.